Kinfo
Labcorp Holdings Inc. logo

Labcorp Holdings Inc.

LHNYSEHealthcare·US · USD
$312.15
-2.05 (-0.65%)
Prices as of October 9, 2026 · market closed

Price

Key statistics

Valuation
Market cap25.32B USD
Enterprise value32.18B USD
Trailing P/E25.99
Forward P/E15.86
PEG ratio0.91
Price / sales1.78
Price / book2.95
Profitability
Gross margin29.80%
Operating margin12.24%
Profit margin6.99%
Return on assets5.53%
Return on equity11.73%
Income (TTM)
Revenue14.35B USD
Gross profit4.14B USD
EBITDA2.26B USD
Net income1.00B USD
Diluted EPS$12.09
Rev. growth (YoY)5.80%
Balance sheet
Total cash141.80M USD
Total debt6.82B USD
Debt / equity79.12
Current ratio1.80
Book value / share$106.39
Cash flow (TTM)
Operating cash flow1.64B USD
Levered free cash flow892.05M USD
Shares & price
Shares outstanding80.90M
Float80.72M
Held by institutions101.79%
Beta0.85
50-day MA$319.90
200-day MA$281.49
52-week high$341.80
52-week low$244.52
Dividends
Forward rate
$2.88
Yield
0.92%
Payout ratio
23.82%
Frequency
Quarterly
Recent payments
  • 2026-08-28$0.72
Earnings (EPS)
DateEst.ActualSurprise2026-07-304.774.99+4.61%2026-04-304.124.25+3.16%2026-03-190.160.17+6.25%2026-02-173.944.07+3.30%2026-02-050.881.04+18.18%
About Labcorp Holdings Inc.

Labcorp Holdings Inc. is a global life sciences and healthcare company that provides laboratory services to support clinical care, research, and drug development. Labcorp Holdings Inc. serves doctors, hospitals, pharmaceutical companies, researchers, and patients through a broad portfolio that includes routine and specialty diagnostic testing, central laboratory services, and early development research support. Its Diagnostics Laboratories segment covers testing in areas such as oncology, women’s health, autoimmune disease, and neurology, while its Biopharma Laboratory Services segment supports pharmaceutical and biotech clients with laboratory capabilities for clinical trials and development programs. The company plays a key role in healthcare by helping customers generate data used in diagnosis, treatment decisions, and biomedical research.

Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Adam H. Schechter
Employees
71,000
Headquarters
Burlington, NC, United States

Frequently asked questions about Labcorp Holdings Inc.